Abu-Freha, N.; Abu-Kosh, O.; Yardeni, D.; Ashur, Y.; Abu-Arar, M.; Yousef, B.; Monitin, S.; Weissmann, S.; Etzion, O.
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life 2023, 13, 1872.
https://doi.org/10.3390/life13091872
AMA Style
Abu-Freha N, Abu-Kosh O, Yardeni D, Ashur Y, Abu-Arar M, Yousef B, Monitin S, Weissmann S, Etzion O.
Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life. 2023; 13(9):1872.
https://doi.org/10.3390/life13091872
Chicago/Turabian Style
Abu-Freha, Naim, Osama Abu-Kosh, David Yardeni, Yaffa Ashur, Muhammad Abu-Arar, Baha Yousef, Shulamit Monitin, Sarah Weissmann, and Ohad Etzion.
2023. "Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents" Life 13, no. 9: 1872.
https://doi.org/10.3390/life13091872
APA Style
Abu-Freha, N., Abu-Kosh, O., Yardeni, D., Ashur, Y., Abu-Arar, M., Yousef, B., Monitin, S., Weissmann, S., & Etzion, O.
(2023). Liver Fibrosis Regression and Associated Factors in HCV Patients Treated with Direct-Acting Antiviral Agents. Life, 13(9), 1872.
https://doi.org/10.3390/life13091872